Stonepine Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Stonepine Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,130,192	Closed	-$12.8M	–	30
2022 Q1	$12.8M	Buy	3,130,192 +832,832	+36%	+$3.02M	5.32%	7
2021 Q4	$8.2M	Buy	2,297,360 +2,033,260	+770%	+$7.11M	3.76%	10
2021 Q3	$961K	Buy	+264,100	New	+$1.07M	0.44%	23
2020 Q4	–	Sell	-1,205,501	Closed	-$3.25M	–	23
2020 Q3	$3.25M	Buy	+1,205,501	New	+$3.34M	3.39%	8
2020 Q2	–	Sell	-151,189	Closed	-$357K	–	23
2020 Q1	$357K	Buy	+151,189	New	+$514K	0.38%	25

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Stonepine Capital Management's ATRS Position: Q2 2022 in Review

Stonepine Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 3,130,192 shares — an estimated $12.8M sold.

Stonepine Capital Management first reported a position in ATRS in Q1 2020 and held it in 5 quarters. The position peaked at $12.8M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Stonepine Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Stonepine Capital Management sold 3,130,192 Antares Pharma, Inc. shares in Q2 2022, an estimated $12.8M.
Stonepine Capital Management first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 5 quarters.
Stonepine Capital Management's Antares Pharma, Inc. position peaked at $12.8M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Stonepine Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.